RealFeedApp Three patients with sickle cell disease became transfusion-independent
Data shows precise correction of the sickle cell mutation and restored adult hemoglobin expression without pain crises.
- Field
- gene therapy
- What they did
- Kamau Therapeutics released preliminary data showing that three patients with sickle cell disease achieved transfusion independence and stopped experiencing pain crises after receiving gene-edited stem cells.
- Why it matters
- This approach aims to eliminate the need for regular blood transfusions and prevent painful crises, which are the main challenges for patients with this condition.
#sickle cell#gene editing#casgevy#hematopoietic stem cells#clinical trial
